Literature DB >> 31187858

Lack of historical evidence to support folic acid exacerbation of the neuropathy caused by vitamin B12 deficiency.

Robert J Berry1.   

Abstract

In 1998 a Tolerable Upper Intake Level (UL) for folic acid was established based on case reports from the 1940s suggesting that high-dosage folic acid intake, used to treat patients with pernicious anemia, had the potential to precipitate or speed-up the development of neurological problems. This UL has been employed in the decision-making process used by more than 80 countries to establish programs to fortify staple foods with folic acid to prevent neural tube birth defects. Some have claimed that this UL is flawed and has become an obstacle to the wider adoption of neural tube defect prevention programs and have called for re-evaluation of the scientific validity of this UL. Case reports cannot establish causality, but they can reveal patterns in the timing of the onset and treatment of patients with pernicious anemia. These patterns can be compared with secular trends of usual medical practice for the treatment of pernicious anemia and with the changes in usage of folic acid preparations, including recommended therapeutic dosage and precautions for its usage surrounding the synthesis of folic acid in 1945 and vitamin B12 in 1948. Folic acid package inserts, early editions of hematology textbooks, and international expert reports provide valuable historical information. The recommended therapeutic daily dosage for folic acid of 5-20 mg was unchanged from 1946 through to 1971. The likely cause of the neurological problems encountered is the development of vitamin B12 neuropathy when pernicious anemia was treated with high-dosage folic acid before vitamin B12 was widely available in the early 1950s. Thus, the historical record does not provide compelling evidence that folic acid can potentially cause neurologic complications among those with low vitamin B12 status and lends support for reconsidering the basis for the UL of folic acid. Published by Oxford University Press on behalf of the American Society for Nutrition 2019.

Entities:  

Keywords:  folate; folic acid; fortification; neural tube defects; neuropathy; pernicious anemia; public health; vitamin B12

Mesh:

Substances:

Year:  2019        PMID: 31187858      PMCID: PMC6785032          DOI: 10.1093/ajcn/nqz089

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  54 in total

1.  Subacute combined degeneration of spinal cord after extensive resection of ileum in Crohn's disease: report of a case.

Authors:  C N BEST
Journal:  Br Med J       Date:  1959-10-31

2.  Folic acid therapy and spinalcord degeneration in pernicious anemia.

Authors:  J N BALDWIN; D J DALESSIO
Journal:  N Engl J Med       Date:  1961-06-29       Impact factor: 91.245

3.  Purification of anti-pernicious anaemia factors from liver.

Authors:  E L SMITH
Journal:  Nature       Date:  1948-04-24       Impact factor: 49.962

4.  Risk of neurological complications in pernicious anaemia treated with folic acid.

Authors:  M C G ISRAELS; J F WILKINSON
Journal:  Br Med J       Date:  1949-11-12

5.  Crystalline Vitamin B12.

Authors:  E L Rickes; N G Brink; F R Koniuszy; T R Wood; K Folkers
Journal:  Science       Date:  1948-04-16       Impact factor: 47.728

6.  The drug efficacy study.

Authors: 
Journal:  N Engl J Med       Date:  1969-05-22       Impact factor: 91.245

7.  Do the benefits of folic acid fortification outweigh the risk of masking vitamin B12 deficiency?

Authors:  James L Mills; Anne M Molloy; Edward H Reynolds
Journal:  BMJ       Date:  2018-03-01

Review 8.  Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-09-11

9.  Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2006.

Authors:  Quanhe Yang; Mary E Cogswell; Heather C Hamner; Alicia Carriquiry; Lynn B Bailey; Christine M Pfeiffer; Robert J Berry
Journal:  Am J Clin Nutr       Date:  2009-10-14       Impact factor: 7.045

Review 10.  Public health failure in the prevention of neural tube defects: time to abandon the tolerable upper intake level of folate.

Authors:  Nicholas J Wald; Joan K Morris; Colin Blakemore
Journal:  Public Health Rev       Date:  2018-01-31
View more
  8 in total

1.  Perspective: The High-Folate-Low-Vitamin B-12 Interaction Is a Novel Cause of Vitamin B-12 Depletion with a Specific Etiology-A Hypothesis.

Authors:  Jacob Selhub; Joshua W Miller; Aron M Troen; Joel B Mason; Paul F Jacques
Journal:  Adv Nutr       Date:  2022-02-01       Impact factor: 11.567

2.  Knowledge gaps in understanding the metabolic and clinical effects of excess folates/folic acid: a summary, and perspectives, from an NIH workshop.

Authors:  Padma Maruvada; Patrick J Stover; Joel B Mason; Regan L Bailey; Cindy D Davis; Martha S Field; Richard H Finnell; Cutberto Garza; Ralph Green; Jean-Louis Gueant; Paul F Jacques; David M Klurfeld; Yvonne Lamers; Amanda J MacFarlane; Joshua W Miller; Anne M Molloy; Deborah L O'Connor; Christine M Pfeiffer; Nancy A Potischman; Joseph V Rodricks; Irwin H Rosenberg; Sharon A Ross; Barry Shane; Jacob Selhub; Sally P Stabler; Jacquetta Trasler; Sedigheh Yamini; Giovanna Zappalà
Journal:  Am J Clin Nutr       Date:  2020-11-11       Impact factor: 7.045

3.  Influences of Folate Supplementation on Homocysteine and Cognition in Patients with Folate Deficiency and Cognitive Impairment.

Authors:  Yuka Hama; Tadanori Hamano; Norimichi Shirafuji; Kouji Hayashi; Asako Ueno; Soichi Enomoto; Miwako Nagata; Hirohiko Kimura; Akiko Matsunaga; Masamichi Ikawa; Osamu Yamamura; Tatsuhiko Ito; Yohei Kimura; Masaru Kuriyama; Yasunari Nakamoto
Journal:  Nutrients       Date:  2020-10-14       Impact factor: 5.717

4.  Influences of Vitamin B12 Supplementation on Cognition and Homocysteine in Patients with Vitamin B12 Deficiency and Cognitive Impairment.

Authors:  Asako Ueno; Tadanori Hamano; Soichi Enomoto; Norimichi Shirafuji; Miwako Nagata; Hirohiko Kimura; Masamichi Ikawa; Osamu Yamamura; Daiki Yamanaka; Tatsuhiko Ito; Yohei Kimura; Masaru Kuriyama; Yasunari Nakamoto
Journal:  Nutrients       Date:  2022-04-02       Impact factor: 5.717

5.  Folic acid and neural tube defects: Discovery, debate and the need for policy change.

Authors:  Nicholas J Wald
Journal:  J Med Screen       Date:  2022-06-23       Impact factor: 1.687

6.  Absorption and Tissue Distribution of Folate Forms in Rats: Indications for Specific Folate Form Supplementation during Pregnancy.

Authors:  Natasha Bobrowski-Khoury; Jeffrey M Sequeira; Erland Arning; Teodoro Bottiglieri; Edward V Quadros
Journal:  Nutrients       Date:  2022-06-09       Impact factor: 6.706

7.  Impact of high-dose folic acid supplementation in pregnancy on biomarkers of folate status and 1-carbon metabolism: An ancillary study of the Folic Acid Clinical Trial (FACT).

Authors:  Malia S Q Murphy; Katherine A Muldoon; Hauna Sheyholislami; Nathalie Behan; Yvonne Lamers; Natalie Rybak; Ruth Rennicks White; Alysha L J Harvey; Laura M Gaudet; Graeme N Smith; Mark C Walker; Shi Wu Wen; Amanda J MacFarlane
Journal:  Am J Clin Nutr       Date:  2021-05-08       Impact factor: 7.045

8.  Efficacy of 4.0 mg versus 0.4 mg Folic Acid Supplementation on the Reproductive Outcomes: A Randomized Controlled Trial.

Authors:  Renata Bortolus; Francesca Filippini; Sonia Cipriani; Daniele Trevisanuto; Francesco Cavallin; Giovanni Zanconato; Edgardo Somigliana; Elena Cesari; Pierpaolo Mastroiacovo; Fabio Parazzini
Journal:  Nutrients       Date:  2021-12-10       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.